This is a preview of subscription content, log in via an institution to check access.
REFERENCES
Cheng Y.-C., Dutschman G., De Clercq E., Jones A.S., Rahim S.G., Verhelst G., Walker R.T. 1981. Differential affinities of 5-(2-halogenovinyl)-2′-deoxyuridines for deoxythymidine kinases of various origins. Mol. Pharmacol. 20, 230–233.
Cheng Y.-C., Dutschman G., Fox J.J., Watanabe K.A., Machida H. 1981. Differential activity of potential anti-viral nucleoside analogues on herpes simplex virus-induced and human cellular thymidine kinases. Antimicrob. Agents Chemother. 20, 420–423.
Fyfe J.A. 1982. Differential phosphorylation of (E)-5-(2-bromovinyl)-2′-deoxyuridine monophosphate by thymidylate kinases from herpes simplex viruses types 1 and 2 and varicella zoster virus. Mol. Pharmacol. 21, 432–437.
Jamieson A.T., Subak-Sharpe J.H. 1974. Biochemical studies on the herpes simplex virus-specified deoxypyrimidine kinase activity. J. Gen. Virol. 24, 481–492.
Kit S., Leung W.-C., Jorgensen G.N., Trkula D., Dubbs D.R. 1975. Viral-induced thymidine kinase isozymes. Prog. Med. Virol. 21, 13–34.
Chen M.S., Summers W.P., Walker J., Summers W.C., Prusoff W.H. 1979. Characterization of pyrimidine deoxyribonucleoside kinase (thymidine kinase) and thymidylate kinase as a multifunctional enzyme in cells transformed by herpes simplex virus type 1 and in cells infected with mutant strains of herpes simplex virus. J. Virol. 30, 942–945.
Elion G.B. 1993. Acyclovir: Discovery, mechanism of action and selectivity. J. Med. Virol. S1, 2–6.
Wild K., Bohner T., Folkers G., Schulz G.E. 1997. The structures of thymidine kinase from herpes simplex virus type 1 in complex with substrates and a substrate analogue. Protein Sci. 6, 2097–2106.
Larder B.A., Cheng Y.-C., Darby G. 1983. Characterization of abnormal thymidine kinases induced by drug-resistant strains of herpes simplex virus type 1. J. Gen. Virol. 64, 523–532.
Hill E.L., Hunter G.A., Ellis M.N. 1991. In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 35, 2322–2328.
L’vov L.D., Andronova V.L., Leont’eva N.A., Galegov G.A. 1999. Isolation of acyclovir-resistant herpes simples virus strains from clinical material. Vopr. Virusol. 44, 247–249.
Safrin S., Elbaggri A., Mills Y. 1992. Patterns of susceptibility acyclovir and foscarnet in 209 herpes simplex virus isolates. Antimicrob. Res. 17, 51.
Aleksandrova L.A., Andronova V.L., Karpenko I.L., Skoblov Yu.S., Adani A., Galegov G.A. 2002. 4′-Thio-5-ethyl-2′deoxyuridine 5′-phosphonates: Synthesis and antiviral properties. Bioorg. Khim. 28, 455–461.
Maniatis T., Fritsh F., Sambrook J. 1989. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor, N.Y.: Cold Spring Harbor Lab. Press.
Chiba A., Suzutani, T., Saijo M., Koyano S., Azuma M. 1998. Analysis of nucleotide sequence variations in herpes simplex virus types 1 and 2, and varicella-zoster virus. Acta Virol. 42, 401–407.
Morfin F., Thouvenot D. 2003. Herpes simplex virus resistance to antiviral drugs. J. Clin. Virol. 26, 29–37.
Wild K., Bohner T., Aubry A., Folkers G., Schulz G.E. 1995. The three-dimensional structures of thymidine kinase from herpes simplex virus type 1. FEBS Lett. 368, 289–292.
Cheng Y.-C., Ostrander M. 1976. Deoxythymidine kinase induced in HeLa TK− cells by herpes simplex virus type I and type II. J. Biol. Chem. 251, 2605–2610.
Author information
Authors and Affiliations
Additional information
Translated from Molekulyarnaya Biologiya, Vol. 39, No. 1, 2005, pp. 155–158.
Original Russian Text Copyright © 2005 by Guskova, Zagurny, M. Skoblov, Baranova, Andronova, Yankovsky, Galegov, Yu. Skoblov.
Rights and permissions
About this article
Cite this article
Guskova, A.A., Zagurny, A.V., Skoblov, M.Y. et al. Molecular genetic analysis of thymidine kinase of the herpes simplex virus type 1. Mol Biol 39, 137–140 (2005). https://doi.org/10.1007/s11008-005-0019-7
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11008-005-0019-7